Table 1.
Combined Rank | Category (term—pathway) | P-value | Fold enrichment | ||
---|---|---|---|---|---|
≥250 R•Y | ≥100 R•Y | ≥250 R•Y | ≥100 R•Y | ||
GO molecuar function | |||||
10 | Ion channel activity | 1.95E−05 | 5.92E−09 | 4.4 | 2.2 |
12 | Protein binding | 3.14E−03 | 6.25E−15 | 1.7 | 1.6 |
20 | Glutamate receptor activity | 6.11E−04 | 1.92E−07 | 10.3 | 4.3 |
GO biological process | |||||
5 | Cell adhesion | 1.11E−04 | 3.36E−12 | 3.4 | 2.2 |
7 | Cell communication | 2.19E−04 | 5.24E−15 | 1.6 | 1.4 |
15 | Transmission of nerve impulse | 1.83E−04 | 5.24E−08 | 5.1 | 2.5 |
GO cellular component | |||||
2 | Membrane | 2.78E−06 | 2.46E−14 | 1.6 | 1.3 |
15 | Synapse | 2.18E−02 | 7.69E−05 | 5.0 | 2.8 |
19 | Extracellular matrix | 4.96E−02 | 1.33E−08 | 2.3 | 2.2 |
Pfam family | |||||
2 | Fibronectin type III | 2.84E−05 | 1.43E−12 | 5.1 | 2.8 |
15 | C-cadherin | 7.76E−05 | 3.14E−05 | 17.0 | 4.3 |
17 | C2 | 1.17E−04 | 3.95E−05 | 5.4 | 2.1 |
PIR family | |||||
3 | α-catenin | 3.55E−04 | 1.20E−03 | 60.4 | 9.4 |
11 | Cadherin | 1.81E−02 | 4.04E−04 | 9.5 | 4.0 |
KEGG pathway | |||||
5 | Neuroactive ligand–receptor interaction | 7.06E−03 | 2.52E−03 | 2.9 | 1.5 |
6 | Phosphatidylinositol signaling system | 2.30E−02 | 1.87E−05 | 4.8 | 2.6 |
7 | Cholera—infection | 1.26E−02 | 3.39E−03 | 6.0 | 2.2 |
Protein interaction partners | |||||
22 | DLG4 | 7.98E−04 | 2.06E−03 | 45.1 | 6.1 |
23 | RAC1 | 8.34E−03 | 9.78E−04 | 7.1 | 2.4 |
Disease association | |||||
4 | Schizophrenia | 5.23E−03 | 2.33E−03 | 7.5 | 2.6 |
Combined Rank, sum of the two categories ranks from Supplementary Tables 2 and 3; categories with one entry were excluded; when more than one category with largely redundant gene entries was present, only one was chosen.